Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding

The main aims of therapy in chronic stable angina are to reduce the risk of myocardial infarction and death and improve symptoms and quality of life (QoL). Unblinded trials have shown that revascularization does not reduce the risk of myocardial infarction or death but does appear to improve symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowbar, Alexandra N, Francis, Darrel P, Al-Lamee, Rasha K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Invited Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519715/
https://www.ncbi.nlm.nih.gov/pubmed/34417901
http://dx.doi.org/10.1007/s10557-021-07198-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519715/
https://www.ncbi.nlm.nih.gov/pubmed/34417901
http://dx.doi.org/10.1007/s10557-021-07198-8

Ejemplares similares